United States · FDA National Drug Code directory
sildenafil CITRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-420_39509319-16be-4fc4-a60a-48ea8e9333c6
- Product NDC
- 59651-420
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- sildenafil CITRATE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221223
- Source listing expiry
- 20271231
Source-listed ingredients
- SILDENAFIL CITRATE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59651-420-11) / 112 mL in 1 BOTTLE · 59651-420-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →